Medovex Corp Stock Price To Sales
Medovex Corp fundamentals help investors to digest information that contributes to Medovex Corp's financial success or failures. It also enables traders to predict the movement of Medovex OTC Stock. The fundamental analysis module provides a way to measure Medovex Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medovex Corp otc stock.
Medovex |
Medovex Corp OTC Stock Price To Sales Analysis
Medovex Corp's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Medovex Corp Price To Sales | 3.68 X |
Most of Medovex Corp's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medovex Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Medovex Corp has a Price To Sales of 3.6766 times. This is 82.82% lower than that of the Healthcare sector and 96.26% lower than that of the Biotechnology industry. The price to sales for all United States stocks is 67.81% higher than that of the company.
Medovex Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medovex Corp's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medovex Corp could also be used in its relative valuation, which is a method of valuing Medovex Corp by comparing valuation metrics of similar companies.Medovex Corp is currently under evaluation in price to sales category among its peers.
Medovex Fundamentals
| Return On Equity | -4.6 | |||
| Return On Asset | -3.48 | |||
| Operating Margin | (3.51) % | |||
| Current Valuation | 8.88 M | |||
| Shares Outstanding | 477.61 K | |||
| Shares Owned By Insiders | 25.51 % | |||
| Number Of Shares Shorted | 294 | |||
| Price To Earning | (1.53) X | |||
| Price To Book | 34.90 X | |||
| Price To Sales | 3.68 X | |||
| Revenue | 1.61 M | |||
| Gross Profit | 906.81 K | |||
| EBITDA | (4.61 M) | |||
| Net Income | (4.8 M) | |||
| Cash And Equivalents | 45.88 K | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 3.88 M | |||
| Debt To Equity | 2.61 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (17.98) X | |||
| Cash Flow From Operations | (4.81 M) | |||
| Short Ratio | 3.47 X | |||
| Earnings Per Share | (0.05) X | |||
| Target Price | 1.75 | |||
| Beta | 0.73 | |||
| Market Capitalization | 1.06 M | |||
| Total Asset | 321.4 K | |||
| Retained Earnings | (38.35 M) | |||
| Working Capital | 3.33 M | |||
| Current Asset | 4.18 M | |||
| Current Liabilities | 851.22 K | |||
| Net Asset | 321.4 K |
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |